SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH M impact

Novo Nordisk Reports 3Q Sales of DKK79.2B

NOVOB
SquawkNews Desk 2 updates Updated Nov 04, 2026, 06:44 AM UTC

Story updates

06:38:17 AM UTC
SquawkNews
Novo Nordisk: 3Q Injectable Wegovy Sales DKK20.41B, Ozempic Sales DKK29.71B
06:44:25 AM UTC
SquawkNews
Novo Nordisk: Initial Sales of Wegovy Pill in International Ops Encouraging, with 3Q Sales Reaching DKK1.22B

Related stories

StubHub Raises Full-Year Gross Merchandise Sales Outlook to $10.3 Billion StubHub raised its full-year gross merchandise sales outlook to $10.3 billion from $10.1 billion. M impact | EARNINGS | Nov 15, 2026, 02:03 AM UTC Merlin Properties Raises 2026 FFO Guidance to EUR 0.58 per Share Merlin Properties raised its 2026 FFO guidance to EUR 0.58 per share and updated its strategy for its 704 MW data center portfolio. M impact | EARNINGS | Nov 14, 2026, 08:03 PM UTC Novo Nordisk Wins EU Approval for FREHEMGO Haemophilia A Therapy The European Commission granted marketing authorization for FREHEMGO (denecimig), a therapy for routine prophylaxis of bleeding episodes in adults and children with haemophilia A, L impact | EQUITY | Nov 14, 2026, 03:25 AM UTC Lucara Diamond Raises 2026 Revenue Guidance to USD 140 Million-160 Million Lucara Diamond Raises 2026 Revenue Guidance to USD 140 Million-160 Million Lucara Diamond raised L impact | EARNINGS | Nov 14, 2026, 01:10 AM UTC Gilead Expects HIV Revenue to Grow About 12% in 2026 Gilead expects HIV revenue to grow about 12% in fiscal 2026. M impact | EARNINGS | Nov 14, 2026, 12:44 AM UTC Asante Gold Withdraws 2026 Production and Cost Guidance Asante withdrew its 2026 guidance for 275,000–300,000 equivalent ounces at consolidated AISC of $3,200–$3,600/oz after Bibiani underperformed. Nine-month production was 165,594 equ M impact | EARNINGS | Nov 13, 2026, 11:27 PM UTC